Home > Offer to Sell > Pharmaceuticals and Biochemicals > Hormones and synthetic substitutes > Levocetirizine Dihydrochloride
Levocetirizine Dihydrochloride
Inquiry
| Post Date: | Jun 11,2015 |
| Expiry Date: | Jun 10,2016 |
| Detailed Description: |
Cas No. :60142-96-3
Quantity: 1Kilograms Specs:1kg/ foil bag with discreet packgae Price:1 USD Kilograms Payment Method: T/T, WesterN Union, Money Gram Product Name: Levocetirizine Dihydrochloride 1. Basic Information: Product Name Levocetirizine Dihydrochloride Synonym Levocetirizine,Levocetirizine 2HCL,Levocetirizine DIHCL,Levocetirizine HCL,Xyzal,Xuzal,Zilola,2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid CAS 130018-87-0 MF C21H27Cl3N2O3 MW 461.81 Assay 99% Quality Standards USP/Pharma Grade Appearance White powder Package 5kg/Drum Place of Origin China Brand Name SMQ Certification ISO9001, ISO14000, KOSHER Model Number 130018-87-0 MOQ 1kg Ref. Price USD 0.73/g Packaging Details 5kg/Drum,1kg/Foil bag Delivery Time 1-2 days Payment Terms T/T, Western union, Money gram Supply Ability 50000 T/Month 2. Quick View: Levocetirizine (as levocetirizine dihydrochloride) is a third-generation non-sedative antihistamine, developed from the second-generation antihistamine cetirizine. Chemically, levocetirizine is the active enantiomer of cetirizine. It is the R-enantiomer of the cetirizine racemate. Levocetirizine works by blocking histamine receptors. It does not prevent the actual release of histamine from mast cells, but prevents it binding to its receptors. This in turn prevents the release of other allergy chemicals and increased blood supply to the area, and provides relief from the typical symptoms of hay fever. 3. History and formulations: (1) Levocetirizine was first launched in 2001 by Belgian pharmaceutical company UCB. It is sold under the brand name Xyzal in Australia, Austria, Croatia, Czech Republic, Finland, France, Ireland, Lithuania, Netherlands, Portugal, Romania, Taiwan, Turkey, The Philippines, United States, Serbia, Slovakia, Slovenia, South Africa and UK; Xuzal in Mexico; Xusal in Germany; Xazal in Spain; and Xozal in Greece. In Hungary it is marketed by Richter Gedeon under the Zilola brand name. (2) In India, levocetirizine is marketed by GlaxoSmithKline and UCB under the brand name Vozet and Xyzal Respectively. On May 25, 2007, the United States Food and Drug Administration approved Xyzal, where it is co-marketed by Sanofi-Aventis. Torrent Pharma launched UVNIL in rural market of India. It is also available as LEZYNCET 5 mg tablets through Unichem in India. In India, generic name of Lev-Cit 5 mg is manufactured by VIP Pharmaceuticals. Also marketed in India by Croslands (Ranbaxy Laboratories Ltd.) under the brand name Teczine. In Brazil it is marketed under the brand name 'Zyxem' by Farmalab. It is marketed in Egypt by BORG Pharma under the brand name 'Xaltec', Allear by western pharmaceuticals and levcet by marcryl. (3) In Pakistan levocetirizine was first launched in liquid formulation by Novartis Consumer Health Division by the name of T-Day Syrup. It is available as 5 mg-strength tablets and a 0.5 mg/mL oral solution. In Pakistan levocetirizine is available in liquid formulation as well with the name of OCITRA and T-Day 2.5 mg/5 mL. In Bangladesh levocetirizine is available in 5 mg tablet & 2.5 mg/5 mL oral liquid formulation with the brand name of Alcet marketed by Healthcare Pharmaceuticals and Seasonix marketed by Incepta Pharmaceuticals. In Nepal levocetirizine is available in 5 mg tablet with brand name of Curin manufactured by Beximco Pharma. |
| CAS Registry Number: | 60142-96-3 |
| Synonyms: | ;neurontin;1-(aminomethyl)cyclohexaneacetic acid;GABAPENTINE;(1-aminomethyl-cyclohexyl)-acetic acid;AKOS 92109;[2-(aminomethyl)cyclohexyl]acetic acid;Capecitabin; |
| Molecular Formula: | C9H17NO2 |
| Molecular Weight: | 171.2368 |
| Molecular Structure: | 
|
| Hazard Symbols: |  T:; |
| Risk Codes: | 61-36/37/38:; |
| Safety Description: | 53-26-36/37/39-45:; |
| Company: | Zhuhai Shuangbojie Technology Co., Ltd [ China ] |
| Contact: | mengruozai |
| Tel: | +86-0765-8889897 |
| Fax: | +86-0765-8889806 |
| Email: | 2355935203@ycphar.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
